Table 4 Factors associated with the risk of loco-regional recurrence for patients with MIBC treated with definite CCRT.

From: The role of PD-L1 in the radiation response and clinical outcome for bladder cancer

Variables

Odd ratios

95% confidence interval

p

PD-L1 staining

0.164

0.047–0.377

0.005*

Clinical stage (T2 vs T3–T4)

3.817

1.026–14.209

0.046*

Treatment response (CR or not)

5.366

1.317–21.858

0.019*

Clinical LN involvement

0.409

0.125–1.337

0.139